We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioFocus Launches www.SilenceSelect.com Microsite
News

BioFocus Launches www.SilenceSelect.com Microsite

BioFocus Launches www.SilenceSelect.com Microsite
News

BioFocus Launches www.SilenceSelect.com Microsite

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BioFocus Launches www.SilenceSelect.com Microsite"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

SilenceSelect consists of over 11,500 shRNAs that can be used to knock-down approximately 5000 different human druggable targets.  All of the protein classes that are considered to be affected by small molecule drugs are well represented.  FLeXSelect is comprised of a collection of over 1,900 full-length human cDNAs that can be used to enhance the expression of specific genes within a cell.  Using the properties of adenovirus vectors, the cDNA or shRNA is effectively delivered into a wide range of targeted human primary cells.  These collections, combined with BioFocus’s unsurpassed expertise in designing disease-relevant high-content and high-throughput screening assays, serve as the basis for target discovery and mechanism of action studies.  The microsite is updated daily with the latest contents of SilenceSelect and FLeXSelect, including the latest gene transcript information from NCBI.


For further information, please visit www.SilenceSelect.com or www.biofocus.com.

Advertisement